- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/57 - Hydrolases (3) acting on peptide bonds (3.4)
Patent holdings for IPC class C12N 15/57
Total number of patents in this class: 391
10-year publication summary
|
8
|
6
|
15
|
10
|
22
|
21
|
16
|
23
|
21
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novozymes A/S | 3342 |
8 |
| Danisco US Inc. | 1123 |
8 |
| Kao Corporation | 5026 |
7 |
| Vertex Pharmaceuticals Incorporated | 1623 |
6 |
| Concordia University | 105 |
5 |
| Peking University First Hospital | 36 |
5 |
| Sanofi-Aventis Deutschland GmbH | 2606 |
4 |
| The Trustees of the University of Pennsylvania | 4382 |
4 |
| Northwestern University | 3478 |
4 |
| Amano Enzyme Inc. | 416 |
4 |
| Jiangnan University | 1575 |
4 |
| The University of Queensland | 669 |
4 |
| Chr. Hansen A/S | 1090 |
4 |
| The Procter & Gamble Company | 21977 |
3 |
| The Regents of the University of California | 20366 |
3 |
| Henkel AG & Co. KGaA | 10686 |
3 |
| Agrivida, Inc. | 62 |
3 |
| The Children's Hospital of Philadelphia | 825 |
3 |
| Immatics Biotechnologies GmbH | 1133 |
3 |
| Ipsen Biopharm Limited | 324 |
3 |
| Other owners | 303 |